The trial posting for EndoBarrier: a Novel therapy for type 2 Diabetes in Obese adults (The ENDO Trial) is not listed as active in clinicaltrials.partners.org database. The trial may have stopped recruiting.

About Obesity:
Being obese increases the risk for many diseases, especially heart disease, stroke, cancer, and diabetes.

According to the Centers for Disease Control and Prevention, obesity has reached epidemic proportions. It has a far-ranging negative effect on health. Persons who are overweight or obese are at increased risk for developing many different health conditions, including heart disease, type 2 diabetes, and bone and joint disease.